Company Profile - Orgenesis Inc

Introduction

Orgenesis Inc (Orgenesis) is a biotechnology company that develops cell and gene therapies for immuno-oncology, viral, metabolic and autoimmune, vascular and musculoskeletal and kidney diseases. It is investigating CD19 CAR-T program against B-Cell acute lymphoblastic leukemia (B-ALL) and lymphoma; metabolic optimized T-cells to treat lung cancer and melanoma; cellular vaccines for solid tumors and pancreatic cancer; CD19.22 CAR-T to treat B-ALL; and CAR-NK cells targeting multiple myeloma and ovarian cancer. The company is also evaluating programs against genital warts, anal dysplasia, chronic pancreatitis, liver, kidney and dermatological diseases, psoriasis, wound healing, osteoarthritis, and other disorders. Orhenesis utilizes POCare platform technology to improve the development of therapies. It works in partnership with academia, research institutes and hospitals. Orgenesis is headquartered in Germantown, Maryland, the US.